TREA

88377819 - MIQURE

Follow

Information

  • Trademark
  • 88377819
  • Serial Number
    88377819
  • Registration Number
    6367204
  • Filing Date
    April 09, 2019
    5 years ago
  • Registration Date
    June 01, 2021
    3 years ago
  • Transaction Date
    January 25, 2024
    11 months ago
  • Status Date
    June 01, 2021
    3 years ago
  • Published for Opposition Date
    March 16, 2021
    3 years ago
  • Location Date
    June 01, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    PARADEWELAI, BENJI YUE
  • Attorney Docket Number
    879750
    Attorney Name
    Julianne Abelman
    Law Office Assigned Location Code
    L10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
MIQURE
Case File Statements
  • GS0051: Medicinal preparations for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases, namely, viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors; Viral systems, gene therapy systems, nucleic acid delivery systems for medical purposes, namely, medicines for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; Pharmaceutical preparations and substances for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; pharmaceutical preparations, vaccines, prophylaxis medicines and other pharmaceutical preparations all for use in nucleic acid-based therapy, gene therapy and cell therapy for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases
  • GS0441: Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics
  • GS0421: Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics
Case File Event Statements
  • 5/26/2023 - a year ago
    33 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF
  • 5/26/2023 - a year ago
    32 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 5/26/2023 - a year ago
    31 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 5/26/2023 - a year ago
    30 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 5/26/2023 - a year ago
    29 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 5/26/2023 - a year ago
    28 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 5/26/2023 - a year ago
    27 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 6/1/2021 - 3 years ago
    26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/16/2021 - 3 years ago
    25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/16/2021 - 3 years ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/24/2021 - 3 years ago
    23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/8/2021 - 3 years ago
    22 - ELECTRONIC RECORD REVIEW COMPLETE Type: FIXD
  • 2/5/2021 - 3 years ago
    21 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR
  • 2/2/2021 - 3 years ago
    20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/2/2021 - 3 years ago
    19 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/2/2021 - 3 years ago
    18 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/2/2021 - 3 years ago
    17 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 2/2/2021 - 3 years ago
    16 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/28/2021 - 3 years ago
    15 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK
  • 6/11/2020 - 4 years ago
    14 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 12/5/2019 - 5 years ago
    13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 12/5/2019 - 5 years ago
    12 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 12/5/2019 - 5 years ago
    11 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 12/4/2019 - 5 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/4/2019 - 5 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/4/2019 - 5 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 11/25/2019 - 5 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/24/2019 - 5 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/24/2019 - 5 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/24/2019 - 5 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/19/2019 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/25/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/12/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP